December 5, 2023 12:34 PM EST
Pharma
Marketing

Mar­ket­ingRx roundup: Phar­mas dou­ble down on re­new­able en­er­gy; Bay­er funds health eq­ui­ty re­search

Beth Snyder Bulik

Senior Editor

At COP28 in Dubai on Mon­day, Schnei­der Elec­tric an­nounced a new co­hort of phar­ma com­pa­nies join­ing its now 2-year-old “En­er­gize” re­new­able en­er­gy pro­gram specif­i­cal­ly for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

A service from the Financial Times